Regulation of Sox2 by STAT3 initiates commitment to the neural precursor cell fate

Stem Cells and Development

Volumn 17, Issue 2, 2008, Pages 269-278

  Foshay, Kara M ^a   Gallicano, G Ian ^a  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC DNA; NESTIN; STAT3 PROTEIN; TRANSCRIPTION FACTOR SOX2;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; IMMUNOPRECIPITATION; MOUSE; NERVE CELL; NERVE CELL DIFFERENTIATION; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SOUTHERN BLOTTING; STEM CELL; WESTERN BLOTTING;

ANIMALS; BASE SEQUENCE; CELL DIFFERENTIATION; CELLS, CULTURED; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HMGB PROTEINS; INTERMEDIATE FILAMENT PROTEINS; MICE; MODELS, BIOLOGICAL; MOLECULAR SEQUENCE DATA; NERVE TISSUE PROTEINS; NEURAL PLATE; NEURONS; PROMOTER REGIONS (GENETICS); STAT3 TRANSCRIPTION FACTOR; TISSUE DISTRIBUTION; TRANSCRIPTION FACTORS; TRANSFECTION;

EID: 43049151475     PISSN: 15473287     EISSN: None     Source Type: Journal    
DOI: 10.1089/scd.2007.0098     Document Type: Article

References (33)

1. Hirabayashi Y and Y Gotoh. (2005). Stage-dependent fate determination of neural precursor cells in mouse forebrain. Neurosci Res 51:331-336.
2. Temple S. (2001). The development of neural stem cells. Nature 414:112-117.
3. Panchision DM and RD McKay. (2002). The control of neural stem cells by morphogenic signals. Curr Opin Genet Dev 12:478-487.
4. Temple S and A Alvarez-Buylla. (1999). Stem cells in the adult mammalian central nervous system. Curr Opin Neurobiol 9:135-141.
5. Israsena N, M Hu, W Fu, L Kan and JA Kessler. (2004). The presence of FGF2 signaling determines whether beta-catenin exerts effects on proliferation or neuronal differentiation of neural stem cells. Dev Biol 268:220-231.
6. Erlandsson A, M Enarsson and K Forsberg-Nilsson. (2001). Immature neurons from CNS stem cells proliferate in response to platelet-derived growth factor. J Neurosci 21:3483-3491.
7. Sun Y, M Nadal-Vicens, S Misono, MZ Lin, A Zubiaga, X Hua, G Fan and ME Greenberg. (2001). Neurogenin promotes neurogenesis and inhibits glial differentiation by independent mechanisms. Cell 104:365-376.
8. Bonni A, Y Sun, M Nadal-Vicens, A Bhatt, DA Frank, I Rozovsky, N Stahl, GD Yancopoulos and ME Greenberg. (1997). Regulation of gliogenesis in the central nervous system by the JAK-STAT signaling pathway. Science 278:477-483.
9. Imada K and WJ Leonard. (2000). The Jak-STAT pathway. Mol Immunol 37:1-11.
10. Yan Y, W Bian, Z Xie, X Cao, I Le Roux, F Guillemot and N Jing. (2004). Stat3 signaling is present and active during development of the central nervous system and eye of vertebrates. Dev Dyn 231:248-257.
11. Gao Q, MJ Wolfgang, S Neschen, K Morino, TL Horvath, GI Shulman and XY Fu. (2004). Disruption of neural signal transducer and activator of transcription 3 causes obesity, diabetes, infertility, and thermal dysregulation. Proc Natl Acad Sci USA 101:4661-4666.
12. Bruning JC, D Gautam, DJ Burks, J Gillette, M Schubert, PC Orban, R Klein, W Krone, D Muller-Wieland and CR Kahn. (2000). Role of brain insulin receptor in control of body weight and reproduction. Science 289:2122-2125.
13. Graus-Porta D, S Blaess, M Senften, A Littlewood-Evans, C Damsky, Z Huang, P Orban, R Klein, JC Schittny and U Muller. (2001). Beta1-class integrins regulate the development of laminae and folia in the cerebral and cerebellar cortex. Neuron 31:367-379.
14. Foshay K, G Rodriguez, B Hoel, J Narayan and GI Gallicano. (2005). JAK2/STAT3 directs cardiomyogenesis within murine embryonic stem cells in vitro. Stem Cells 23:530-543.
15. Caldenhoven E, TB van Dijk, R Solari, J Armstrong, JA Raaijmakers, JW Lammers, L Koenderman and RP de Groot. (1996). STAT3beta, a splice variant of transcription factor STAT3, is a dominant negative regulator of transcription. J Biol Chem 271:13221-13227.
16. Boyer LA, TI Lee, MF Cole, SE Johnstone, SS Levine, JP Zucker, MG Guenther, RM Kumar, HL Murray, RG Jenner, DK Gifford, DA Melton, R Jaenisch and RA Young. (2005). Core transcriptional regulatory circuitry in human embryonic stem cells. Cell 122:947-956.
17. Lobo MV, MI Arenas, FJ Alonso, G Gomez, E Bazan, CL Paino, E Fernandez, B Fraile, R Paniagua, A Moyano and E Caso. (2004). Nestin, a neuroectodermal stem cell marker molecule, is expressed in Leydig cells of the human testis and in some specific cell types from human testicular tumours. Cell Tissue Res 316:369-376.
18. Messam CA, J Hou and EO Major. (2000). Coexpression of nestin in neural and glial cells in the developing human CNS defined by a human-specific anti-nestin antibody. Exp Neurol 161:585-596.
19. Roy NS, A Benraiss, S Wang, RA Fraser, R Goodman, WT Couldwell, M Nedergaard, A Kawaguchi, H Okano and SA Goldman. (2000). Promoter-targeted selection and isolation of neural progenitor cells from the adult human ventricular zone. J Neurosci Res 59:321-331.
20. Tomioka M, M Nishimoto, S Miyagi, T Katayanagi, N, Fukui, H Niwa, M Muramatsu and A Okuda. (2002).Identification of Sox-2 regulatory region which is under the control of Oct-3/4-Sox-2 complex. Nucleic Acids Res 30:3202-3213.
21. Tanaka S, Y Kamachi, A Tanouchi, H Hamada, N Jing and H Kondoh. (2004). Interplay of SOX and POU factors in regulation of the Nestin gene in neural primordial cells. Mol Cell Biol 24:8834-8846.
22. Ferri AL, M Cavallaro, D Braida, A Di Cristofano, ACanta, A Vezzani, S Ottolenghi, PP Pandolfi, M Sala, S DeBiasi and SK Nicolis. (2004). Sox2 deficiency causes neurodegeneration and impaired neurogenesis in the adult mouse brain. Development 131:3805-3819.
23. Catena R, C Tiveron, A Ronchi, S Porta, A Ferri, L Tatangelo, M Cavallaro, R Favaro, S Ottolenghi, R Reinbold, H Scholer and SK Nicolis. (2004). Conserved POU binding DNA sites in the Sox2 upstream enhancer regulate gene expression in embryonic and neural stem cells. J Biol Chem 279:41846-41857.
24. Wiebe MS, PJ Wilder, D Kelly and A Rizzino. (2000). Isolation, characterization, and differential expression of the murine Sox-2 promoter. Gene 246:383-393.
25. Catlett-Falcone R, TH Landowski, MM Oshiro, J Turkson, A Levitzki, R Savino, G Ciliberto, L Moscinski, JL Fernandez-Luna, G Nunez, WS Dalton and R Jove. (1999). Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells. Immunity 10:105-115.
26. Cheng L, SWang, YJ Ye, JQ Zhang, XM Qiao, DQ Yang and ZR Cui. [The effect of transfecting Stat3beta cDNA on human breast cancer]. Zhonghua Yi Xue Za Zhi 85:23-27.
27. Yeh M, NM Gharavi, J Choi, X Hsieh, E Reed, KP Mouillesseaux, AL Cole, ST Reddy and JA Berliner. (2004). Oxidized phospholipids increase interleukin 8 (IL-8) synthesis by activation of the c-src/signal transducers and activators of transcription (STAT)3 pathway. J Biol Chem 279:30175-30181.
28. Ziros PG, T Georgakopoulos, I Habeos, EK Basdra and A Papavassiliou. (2004). Growth hormone attenuates the transcriptional activity of Runx2 by facilitating its physical association with Stat3beta. J Bone Miner Res 19:1892-1904.
29. Wu R, S Sun and BM Steinberg. (2003). Requirement of STAT3 activation for differentiation of mucosal stratified squamous epithelium. Mol Med 9:77-84.
30. Shimozaki K, K Nakajima, T Hirano and S Nagata. (1997). Involvement of STAT3 in the granulocyte colony-stimulating factor-induced differentiation of myeloid cells. J Biol Chem 272:25184-25189.
31. Laouar Y, T Welte, XY Fu and R Flavell. (2003). A. STAT3 is required for Flt3L-dependent dendritic cell differentiation. Immunity 19:903-912.
32. Park SJ, T Nakagawa, H Kitamura, T Atsumi, H Kamon, S Sawa, D Kamimura, N Ueda, Y Iwakura, K Ishihara, M Murakami and T Hirano. (2004). IL-6 regulates in vivo dendritic cell differentiation through STAT3 activation. J Immunol 173:3844-3854.
33. Graham V, J Khudyakov, P Ellis and L Pevny. (2003). SOX2 functions to maintain neural progenitor identity. Neuron 39:749-765.